Karen B Garcia, MD
Obstetrics/Gynecology · Watsonville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Salud Para La Gente · 41 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Garcia’s office at (831) 728-8250 to ask if they take your plan before you enroll.
California Medical Board record
Licence G76801 · Current
Licensed to practise in California · since 1993 · expires 2028-07-31 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$146,476
Pharmacies billed $146,476 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
372 generic and 139 brand-name prescriptions · $146,476 in drug cost · 58 antibiotic prescriptions to 39 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 79 | $87,972 | $1,114 |
| Estring | 39 | $23,841 | $611 |
| Mirabegron Er | 21 | $13,876 | $661 |
| Estradiol | 121 | $6,162 | $51 |
| Yuvafem | 46 | $4,991 | $108 |
See all 9 drugs
| Myrbetriq | 79 | $87,972 | $1,114 |
| Estring | 39 | $23,841 | $611 |
| Mirabegron Er | 21 | $13,876 | $661 |
| Estradiol | 121 | $6,162 | $51 |
| Yuvafem | 46 | $4,991 | $108 |
| Trospium Chloride | 39 | $1,953 | $50 |
| Climara | 12 | $1,661 | $138 |
| Methenamine Hippurate | 16 | $1,545 | $97 |
| Nitrofurantoin Mono-Macro | 26 | $248 | $10 |
Year by year
| 2024 | 511 | 198 | None | 27% | $146,476 |
| 2023 | 791 | 270 | 2% (15) | 26% | $208,326 |
| 2022 | 834 | 260 | 2% (17) | 29% | $211,211 |
| 2021 | 590 | 226 | None | 23% | $100,754 |
| 2020 | 446 | 154 | 3% (13) | 17% | $61,811 |
| 2019 | 490 | 199 | None | 22% | $71,479 |
| 2018 | 372 | 168 | None | 24% | $53,006 |
| 2017 | 404 | 157 | 5% (18) | 17% | $63,087 |
| 2016 | 353 | 155 | 5% (16) | 24% | $62,698 |
| 2015 | 345 | 146 | 3% (11) | 28% | $53,003 |
| 2014 | 446 | 154 | 5% (21) | 24% | $59,277 |
| 2013 | 414 | 153 | 6% (23) | 33% | $62,998 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Myrbetriq | 116 | $141,103 | $1,216 |
| Estring | 53 | $31,450 | $593 |
| Estradiol | 195 | $8,447 | $43 |
| Trospium Chloride Er | 26 | $5,344 | $206 |
| Yuvafem | 43 | $4,956 | $115 |
| Methenamine Hippurate | 18 | $2,391 | $133 |
| Trospium Chloride | 45 | $2,264 | $50 |
| Climara | 13 | $1,891 | $145 |
| Nitrofurantoin | 15 | $467 | $31 |
| Nitrofurantoin Mono-Macro | 23 | $339 | $15 |
| Hydrocortisone | 23 | $275 | $12 |
| Cefadroxil | 24 | $271 | $11 |
| Ciprofloxacin | 16 | $122 | $8 |
| Sulfamethoxazole-Trimethoprim | 17 | $116 | $7 |
| Ibuprofen | 11 | $91 | $8 |
2022: 16 drugs
| Myrbetriq | 147 | $144,214 | $981 |
| Estring | 63 | $35,685 | $566 |
| Estradiol | 213 | $9,304 | $44 |
| Trospium Chloride | 55 | $3,085 | $56 |
| Yuvafem | 18 | $2,773 | $154 |
| Methenamine Hippurate | 16 | $2,495 | $156 |
| Climara | 15 | $2,251 | $150 |
| Trospium Chloride Er | 15 | $2,203 | $147 |
| Nitrofurantoin Mono-Macro | 29 | $540 | $19 |
| Hydrocortisone | 22 | $244 | $11 |
| Cephalexin | 14 | $194 | $14 |
| Sulfamethoxazole-Trimethoprim | 30 | $190 | $6 |
| Medroxyprogesterone Acetate | 13 | $179 | $14 |
| Cefadroxil | 17 | $150 | $9 |
| Ibuprofen | 18 | $140 | $8 |
| Hydrocodone-Acetaminophen | 11 | $84 | $8 |
2021: 15 drugs
| Myrbetriq | 73 | $66,403 | $910 |
| Estradiol | 160 | $7,773 | $49 |
| Estring | 13 | $7,162 | $551 |
| Methenamine Hippurate | 13 | $2,948 | $227 |
| Trospium Chloride | 52 | $2,677 | $51 |
| Climara | 14 | $2,184 | $156 |
| Yuvafem | 11 | $1,588 | $144 |
| Nitrofurantoin Mono-Macro | 23 | $971 | $42 |
| Oxybutynin Chloride Er | 11 | $770 | $70 |
| Trimethoprim | 12 | $530 | $44 |
| Scopolamine | 11 | $200 | $18 |
| Cephalexin | 14 | $161 | $12 |
| Sulfamethoxazole-Trimethoprim | 21 | $134 | $6 |
| Cefadroxil | 11 | $110 | $10 |
| Ibuprofen | 13 | $101 | $8 |
2020: 10 drugs
| Myrbetriq | 22 | $27,932 | $1,270 |
| Estradiol | 126 | $7,977 | $63 |
| Trospium Chloride Er | 17 | $4,686 | $276 |
| Methenamine Hippurate | 14 | $3,627 | $259 |
| Trospium Chloride | 52 | $2,978 | $57 |
| Climara | 15 | $2,329 | $155 |
| Oxybutynin Chloride Er | 15 | $537 | $36 |
| Medroxyprogesterone Acetate | 16 | $319 | $20 |
| Cephalexin | 21 | $314 | $15 |
| Ibuprofen | 12 | $94 | $8 |
2019: 12 drugs
| Myrbetriq | 14 | $15,619 | $1,116 |
| Estradiol | 119 | $8,070 | $68 |
| Estrace | 26 | $7,956 | $306 |
| Trospium Chloride Er | 23 | $7,828 | $340 |
| Climara | 20 | $3,087 | $154 |
| Oxybutynin Chloride Er | 27 | $2,073 | $77 |
| Trospium Chloride | 29 | $1,749 | $60 |
| Nitrofurantoin Mono-Macro | 23 | $494 | $21 |
| Medroxyprogesterone Acetate | 13 | $274 | $21 |
| Cephalexin | 24 | $231 | $10 |
| Sulfamethoxazole-Trimethoprim | 19 | $114 | $6 |
| Ibuprofen | 13 | $113 | $9 |
2018: 11 drugs
| Estrace | 73 | $9,049 | $124 |
| Trospium Chloride Er | 19 | $8,329 | $438 |
| Climara | 17 | $2,499 | $147 |
| Yuvafem | 15 | $2,414 | $161 |
| Trospium Chloride | 16 | $1,771 | $111 |
| Oxybutynin Chloride Er | 29 | $1,341 | $46 |
| Estradiol | 16 | $563 | $35 |
| Medroxyprogesterone Acetate | 14 | $332 | $24 |
| Nitrofurantoin Mono-Macro | 11 | $239 | $22 |
| Cephalexin | 13 | $141 | $11 |
| Sulfamethoxazole-Trimethoprim | 15 | $100 | $7 |
2017: 11 drugs
| Estrace | 86 | $27,137 | $316 |
| Trospium Chloride Er | 22 | $9,960 | $453 |
| Yuvafem | 12 | $4,200 | $350 |
| Climara | 18 | $2,361 | $131 |
| Oxybutynin Chloride Er | 31 | $1,596 | $51 |
| Trospium Chloride | 19 | $1,460 | $77 |
| Medroxyprogesterone Acetate | 17 | $507 | $30 |
| Trimethoprim | 13 | $461 | $35 |
| Ibuprofen | 20 | $235 | $12 |
| Sulfamethoxazole-Trimethoprim | 25 | $190 | $8 |
| Cephalexin | 13 | $147 | $11 |
2016: 9 drugs
| Estrace | 79 | $22,467 | $284 |
| Vagifem | 15 | $8,180 | $545 |
| Trospium Chloride Er | 14 | $6,346 | $453 |
| Oxybutynin Chloride Er | 32 | $3,448 | $108 |
| Climara | 17 | $1,932 | $114 |
| Trospium Chloride | 17 | $1,239 | $73 |
| Medroxyprogesterone Acetate | 13 | $273 | $21 |
| Ibuprofen | 20 | $226 | $11 |
| Sulfamethoxazole-Trimethoprim | 19 | $147 | $8 |
2015: 10 drugs
| Estrace | 69 | $16,562 | $240 |
| Vagifem | 15 | $6,114 | $408 |
| Estring | 19 | $5,765 | $303 |
| Oxybutynin Chloride Er | 29 | $4,049 | $140 |
| Premarin | 11 | $2,714 | $247 |
| Climara | 16 | $1,818 | $114 |
| Trospium Chloride | 14 | $1,379 | $98 |
| Imipramine | 12 | $312 | $26 |
| Nitrofurantoin Mono-Macro | 11 | $260 | $24 |
| Sulfamethoxazole-Trimethoprim | 11 | $78 | $7 |
2014: 15 drugs
| Estrace | 73 | $15,166 | $208 |
| Trospium Chloride Er | 18 | $8,442 | $469 |
| Estring | 22 | $5,927 | $269 |
| Vagifem | 15 | $4,651 | $310 |
| Oxybutynin Chloride Er | 22 | $2,805 | $128 |
| Trospium Chloride | 19 | $2,005 | $106 |
| Premarin | 11 | $1,980 | $180 |
| Climara | 13 | $1,477 | $114 |
| Duloxetine | 11 | $1,421 | $129 |
| Medroxyprogesterone Acetate | 11 | $230 | $21 |
| Estradiol | 13 | $226 | $17 |
| Cephalexin | 11 | $208 | $19 |
| Ibuprofen | 17 | $196 | $12 |
| Hydrocodone-Acetaminophen | 13 | $128 | $10 |
| Sertraline | 11 | $114 | $10 |
2013: 13 drugs
| Estrace | 78 | $14,677 | $188 |
| Vagifem | 30 | $8,036 | $268 |
| Oxytrol | 24 | $5,195 | $216 |
| Oxybutynin Chloride Er | 28 | $3,987 | $142 |
| Estring | 15 | $3,671 | $245 |
| Premarin | 18 | $3,551 | $197 |
| Trospium Chloride | 16 | $2,312 | $145 |
| Climara | 12 | $1,363 | $114 |
| Estradiol | 17 | $553 | $33 |
| Cephalexin | 16 | $301 | $19 |
| Ibuprofen | 19 | $184 | $10 |
| Hydrocodone-Acetaminophen | 15 | $146 | $10 |
| Sulfamethoxazole-Trimethoprim | 14 | $88 | $6 |
Money from drug and device companies
$208 in 2024
A payment is not proof that care is biased.
| Biogen | None | $121 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $87 | 1 payment
|
See all 2 published payments
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2024-05-30 | Xifaxan | $87 |
| Biogen | Meals · 2024-04-02 | None | $121 |
Professional record
- NPI
- 1043396567
- Licence
- CA G76801California G76801: Current · expires 2028-07-31
- Trained
- University of California, Davis School of Medicine, 1991
- Group
- Salud Para La Gente
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G768010
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2006-10-27
- NPI last updated
- 2021-12-06
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.